NASDAQ: ACRS Long Term Investor Alert: Investigation of Potential Wrongdoing at Aclaris Therapeutics, Inc.
December 12, 2019 at 13:00 PM EST
San Diego, CA -- (SBWIRE) -- 12/12/2019 -- An investigation on behalf of current long term investors in Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares over possible breaches of fiduciary duty by certain officers and directors was announced.